Danielle Brandman, M.D.

Transplant Hepatology

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

I am happy to return to the east coast to join the Weill Cornell team as medical director of liver transplantation after having spent the past 17 years at the University of California San Francisco (UCSF).  

I find the liver to be the most fascinating organ in the body, and am thankful that liver transplantation is available to patients with advanced liver disease.  I have seen the impact that liver disease can have on patients’ lives and feel honored to be part of a team that will help improve longevity and quality of life. I am passionate about providing high quality care for all patients I encounter. I value the long-term relationships I build with my patients.  It is incredibly gratifying to me to see my patients experience successes, from a 5-pound weight loss to improve liver health to undergoing a successful liver transplant.  

I care for patients with a broad spectrum of liver diseases. I have special expertise in the management of nonalcoholic/metabolic dysfunction-associated fatty liver disease, as well as polycystic liver disease.   I am engaged in research focusing on outcomes of liver transplant in patients who have fatty liver as the reason for transplant. I have collaborated with primary care providers to develop systems to identify patients with fatty liver who will derive the most benefit from being linked to hepatology care.

My personal interests include fitness (I am a certified Zumba instructor), dance, hiking, and travel.  I am excited to re-acquaint myself with New York and experience all it has to offer. I am happy to return to the east coast to join the Weill Cornell team as medical director of liver transplantation after having spent the past 17 years at the University of California San Francisco (UCSF).  

Biographical Info

Dr. Danielle Brandman is the director of the Center for Liver Disease and Transplantation at Weill Cornell Medicine in New York City.  She specializes management of patients with liver diseases including autoimmune liver disease, viral hepatitis B and C, fatty liver disease, metabolic liver disease, and liver cancers. She sees patients with end-stage liver disease (cirrhosis) and evaluates those who need liver transplantation. She provides medical care to patients before and after liver transplantation. She has a special interest in the care of patients with fatty liver disease.

She received her undergraduate Bachelor of Arts in Biology and Psychology (with distinction) from Boston University, and graduated from Rutgers (formerly UMDNJ) New Jersey Medical School in Newark, New Jersey, where she was inducted into the Alpha Omega Alpha Honor Medical Society and the Gold Humanism Honor Society. She completed all of her post-graduate medical training at the University of California San Francisco (UCSF), including internal medicine in 2008, gastroenterology fellowship in 2011, and transplant hepatology in 2012.  During her gastroenterology fellowship, she completed a Master’s of Advanced Studies in Clinical Research in 2011. 

In 2012, she joined the faculty at UCSF, where she served an integral role in the education of medical students, residents, fellows, and nurse practitioners.  She was the director of the intern and resident required and elective rotations in liver transplantation and hepatology.  She served as the Program Director for the ACGME-certified Transplant Hepatology Fellowship.  She was a key educator in hepatology and liver transplantation for internal medicine residents and subspecialty fellows.  Her teaching skills were recognized with an Excellence in Teaching Award from the UCSF Haile T. Debas Academy of Medical Educators in 2015.  She has provided formal and informal mentorship to numerous trainees. She received the Mentor of the Year Award by the UCSF Clinical and Translational Science Institute Resident Research Program.  She has served as a mentor for the American Association for the Study of Liver Disease (AASLD) for several Emerging Liver Scholars.   

Board Certifications
American Board of Internal Medicine
American Board of Internal Medicine (Gastroenterology)
American Board of Internal Medicine (Transplant Hepatology)
Clinical Expertise
Liver Cancer
Viral Hepatitis
Portal Hypertension
Primary Sclerosing Cholangitis
Primary Biliary Cholangitis
Autoimmune Hepatitis
Donor Evaluation
General Hepatology
Genetic Liver Diseases
Genetic Screening
Hepatitis B
Hepatitis C
Polycystic Liver Disease
Alpha-1-Antitrypsin Deficiency
Liver Cysts
Liver Lesions
Liver Nodules
Wilson's Disease
Liver Masses
  • M.A.S.
    University of California, San Francisco
  • M.D.
    Rutgers New Jersey Medical School
  • B.A.
    Boston University
  • Adjunct Assistant Professor of Clinical Medicine (Interim)
    Columbia University College of Physicians and Surgeons
  • Attending Physician
    NewYork-Presbyterian Hospital
  • Professor of Clinical Medicine
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

No External Relationships Reported